These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 31313885)
1. The HLA-DRB1 risk alleles for multiple sclerosis are differentially expressed in blood cells of patients from Southern Italy. Pisapia L; Cerillo I; Farina F; Zimbardo A; Barba P; Orefice G; Gianfrani C; Strazzullo M; Del Pozzo G Int J Immunogenet; 2019 Dec; 46(6):479-484. PubMed ID: 31313885 [TBL] [Abstract][Full Text] [Related]
2. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis. Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586 [TBL] [Abstract][Full Text] [Related]
3. Frequency of HLA-DRB1 gene alleles in patients with multiple sclerosis in a Lithuanian population. Balnytė R; Rastenytė D; Mickevičienė D; Vaitkus A; Skrodenienė E; Vitkauskienė A Medicina (Kaunas); 2012; 48(1):9-14. PubMed ID: 22370504 [TBL] [Abstract][Full Text] [Related]
4. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population. Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784 [TBL] [Abstract][Full Text] [Related]
5. Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod. Watanabe M; Nakamura Y; Isobe N; Tanaka M; Sakoda A; Hayashi F; Kawano Y; Yamasaki R; Matsushita T; Kira JI J Neuroinflammation; 2020 Jul; 17(1):206. PubMed ID: 32646493 [TBL] [Abstract][Full Text] [Related]
6. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status. Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835 [TBL] [Abstract][Full Text] [Related]
7. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran. Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442 [TBL] [Abstract][Full Text] [Related]
8. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study. Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J; J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848 [TBL] [Abstract][Full Text] [Related]
9. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk. Nolan D; Castley A; Tschochner M; James I; Qiu W; Sayer D; Christiansen FT; Witt C; Mastaglia F; Carroll W; Kermode A Neurology; 2012 Aug; 79(6):538-46. PubMed ID: 22786591 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Agliardi C; Guerini FR; Saresella M; Caputo D; Leone MA; Zanzottera M; Bolognesi E; Marventano I; Barizzone N; Fasano ME; Al-Daghri N; Clerici M Brain Behav Immun; 2011 Oct; 25(7):1460-7. PubMed ID: 21664963 [TBL] [Abstract][Full Text] [Related]
11. Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Romero-Pinel L; Martínez-Yélamos S; Bau L; Matas E; Gubieras L; María Pujal J; Morandeira F; Bas J; Arbizu T Eur J Neurol; 2011 Oct; 18(10):1258-62. PubMed ID: 21418440 [TBL] [Abstract][Full Text] [Related]
12. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population. Čierny D; Lehotský J; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Michalik J Neurol Res; 2018 Jul; 40(7):607-614. PubMed ID: 29619906 [TBL] [Abstract][Full Text] [Related]
13. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. DeLuca GC; Ramagopalan SV; Herrera BM; Dyment DA; Lincoln MR; Montpetit A; Pugliatti M; Barnardo MC; Risch NJ; Sadovnick AD; Chao M; Sotgiu S; Hudson TJ; Ebers GC Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20896-901. PubMed ID: 18087043 [TBL] [Abstract][Full Text] [Related]
14. Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring. Guijarro-Castro C; Sanchez-Zapardiel E; Munoz D; Fernandez O; Leyva L; Castro-Panete MJ; Picon-Munoz C; Talise M; Martinez-Feito A; Paz-Artal E Rev Neurol; 2016 Sep; 63(5):201-5. PubMed ID: 27569565 [TBL] [Abstract][Full Text] [Related]
15. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study. Apperson ML; Tian Y; Stamova B; Ander BP; Jickling GC; Agius MA; Sharp FR J Neuroimmunol; 2013 Apr; 257(1-2):90-6. PubMed ID: 23477965 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. Gajofatto A; Stefani A; Turatti M; Bianchi MR; Lira MG; Moretto G; Salviati A; Benedetti MD Eur J Neurol; 2013 Apr; 20(4):697-703. PubMed ID: 23279712 [TBL] [Abstract][Full Text] [Related]
17. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania. Balnyte R; Rastenyte D; Vaitkus A; Mickeviciene D; Skrodeniene E; Vitkauskiene A; Uloziene I BMC Neurol; 2013 Jul; 13():77. PubMed ID: 23837503 [TBL] [Abstract][Full Text] [Related]
18. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas]. Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262 [TBL] [Abstract][Full Text] [Related]
19. The impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile. Skarlis C; Markoglou N; Gontika M; Artemiadis A; Pons MR; Stefanis L; Dalakas M; Chrousos G; Anagnostouli M Neurol Sci; 2024 Nov; 45(11):5405-5411. PubMed ID: 38819529 [TBL] [Abstract][Full Text] [Related]
20. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II. Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]